YOLFTbeta
Shin Poong Pharm.Co.Ltd.

Shin Poong Pharm.Co.Ltd.

019170 · KO · Healthcare / Drug Manufacturers - Specialty & Generic

7,920.00KRW-110.00 (-1.37%)

Price History

Full chart

Market Stats

Previous Close8,030.00
Open8,010.00
Day Range7,850.00 – 8,130.00
52-Week Range6,310.00 – 15,900.00
Volume112.20K
Market Cap503.70B
P/E (TTM)0.00
Forward P/E17.73
Dividend Yield0.00%
Beta1.16
50-Day Avg8,977.80
200-Day Avg10,636.50

About

Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; wound dressings; health functional food; and over the counter products. In addition, the company engages in business management and exports its products to approximately 50 countries. The company was founded in 1962 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Jei-Man Ryu
  • Employees809
  • Headquarters161, Yeoksam-ro, Seoul, South Korea, 06246, Korea
  • Websitehttps://shinpoong.co.kr

Leadership

  • Mr. Jei-Man RyuCEO & Inside Director · b. 1956
  • InIl JeongHead of Financial Management Division
  • Mr. JooYoung SungMD & Inside Director · b. 1965

Financials

Income Statement

Currency: KRW2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue125.92B140.83B152.65B158.77B165.92B188.14B217.26B232.06B229.69B221.17B215.96B220.29B195.95B194.15B185.00B187.39B189.72B197.75B189.24B209.29B200.23B221.09B234.68B
Growth (%)-+11.83%+8.39%+4.01%+4.50%+13.39%+15.48%+6.81%-1.02%-3.71%-2.35%+2.00%-11.05%-0.92%-4.71%+1.29%+1.24%+4.23%-4.31%+10.60%-4.33%+10.42%+6.15%
Cost of Revenue62.92B72.93B74.49B76.22B81.05B86.56B105.68B114.93B119.49B124.66B111.66B110.13B109.36B106.22B104.88B111.50B113.54B121.22B111.85B131.31B119.95B139.29B132.01B
Gross Profit----------95.51B100.81B86.59B87.93B80.12B75.89B76.18B76.53B77.39B77.97B80.28B81.80B102.67B
Gross Margin----------44.23%45.76%44.19%45.29%43.31%40.50%40.16%38.70%40.89%37.26%40.09%37.00%43.75%
Operating Expense----------70.70B81.56B82.35B78.36B72.31B68.13B70.58B68.68B91.69B0127.67B98.83B88.42B
Operating Income23.81B16.88B25.34B22.44B19.18B31.24B35.27B43.97B38.45B24.23B24.81B19.25B4.24B9.57B7.81B7.75B5.60B7.85B-14.31B77.97B-47.39B-17.03B14.26B
Operating Margin18.91%11.99%16.60%14.13%11.56%16.60%16.23%18.95%16.74%10.96%11.49%8.74%2.16%4.93%4.22%4.14%2.95%3.97%-7.56%37.26%-23.67%-7.70%6.07%
EBITDA--------------16.02B20.83B23.55B23.49B3.89B-21.92B-39.81B-27.14M22.53B
EBITDA Margin--------------8.66%11.12%12.41%11.88%2.06%-10.47%-19.88%-0.01%9.60%
Net Income13.21B1.33B11.77B21.81B8.33B11.36B19.87B20.51B23.47B13.59B5.13B3.16B1.48B-18.59B904.89M2.80B5.32B5.00B-11.58B-35.38B-57.33B-15.39B8.83B
Net Income Margin10.49%0.94%7.71%13.74%5.02%6.04%9.15%8.84%10.22%6.14%2.38%1.44%0.75%-9.58%0.49%1.50%2.81%2.53%-6.12%-16.90%-28.63%-6.96%3.76%
R&D-------5.09B4.82B-14.48B15.62B9.14B6.39B4.63B4.87B5.97B5.62B17.33B30.38B42.28B17.88B10.44B
R&D as % of Total Revenue-------2.20%2.10%-6.70%7.09%4.66%3.29%2.50%2.60%3.14%2.84%9.16%14.52%21.11%8.09%4.45%
Interest Expense0000000000000004.28B4.11B2.94B202.06M61.42M1.72B2.63B2.69B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%2.28%2.17%1.49%0.11%0.03%0.86%1.19%1.15%

Balance Sheet

Currency: KRW2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets166.19B174.77B190.07B201.07B217.16B268.61B310.15B320.93B378.50B379.68B398.35B409.30B410.73B416.49B385.61B380.95B380.11B487.15B392.58B361.54B350.08B342.09B352.47B
Total Liabilities77.60B87.42B92.42B94.79B103.35B140.67B164.84B170.54B198.64B190.95B207.57B217.78B215.87B199.64B175.50B173.47B170.99B112.82B38.03B30.78B79.30B84.00B81.74B
Total Equity87.80B87.10B97.43B106.03B113.62B127.57B144.97B150.04B179.56B188.48B190.50B191.21B193.46B216.55B209.81B206.47B208.18B373.37B353.49B329.61B269.59B256.82B269.97B
Cash1.45B2.44B2.57B5.11B2.85B540.58M2.23B1.80B3.41B5.18B9.89B5.97B12.67B16.09B19.42B37.17B23.37B55.80B27.64B41.69B43.80B41.99B47.43B
Net Debt--------------93.14B70.27B82.68B---1.20B11.32B7.53B

Cash Flow

Currency: KRW2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-10.49B4.93B10.71B9.77B23.57B9.82B11.36B28.73B30.79B11.45B-48.16M9.89B18.96B10.15B32.05B19.35B20.06B-71.03B-26.44B-24.81B-15.15B17.25B
Investing Cash Flow-----------17.46B-13.20B-112.94M-21.16B2.04B-10.31B-30.66B-94.96B49.03B----
Financing Cash Flow-1.27M538.83M-9.06B16.69B23.80B5.11B--10.74B9.32B-3.15B5.52B-8.50B-4.15B-2.49B108.65B-6.42B----
Capital Expenditure07.83B7.86B8.41B21.01B43.58B30.28B14.53B19.98B19.07B9.39B7.38B1.90B1.50B3.08B1.79B12.07B2.65B4.42B6.23B15.03B6.09B3.99B
Free Cash Flow--------------6.59B30.21B5.17B16.94B-76.64B-32.67B-39.84B-21.24B13.26B
Dividends Paid-1.47B890.87M1.24B1.61B1.78B1.78B2.13B2.13B2.19B2.28B1.59B2.06B--5.16B5.16B5.16B5.16B----
FCF to OCF--------------64.94%94.26%26.72%84.45%107.91%123.56%160.59%140.18%76.87%
Dividend Paid to FCF---------------17.06%99.72%30.43%-6.73%----

Earnings

Report DateJun 1, 2011Aug 31, 2011Nov 30, 2011Feb 29, 2012May 30, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Sep 3, 2014Dec 3, 2014Feb 25, 2015Jun 3, 2015Sep 2, 2015Dec 2, 2015Mar 2, 2016May 16, 2016Aug 16, 2016Nov 14, 2016Mar 7, 2017May 15, 2017Aug 14, 2017Nov 14, 2017Mar 7, 2018May 30, 2018Aug 14, 2018Nov 14, 2018Mar 21, 2019May 15, 2019Aug 13, 2019Nov 14, 2019Feb 10, 2020May 15, 2020Aug 14, 2020Nov 16, 2020Mar 22, 2021May 17, 2021Aug 17, 2021Nov 15, 2021May 16, 2022Aug 16, 2022Nov 14, 2022Mar 23, 2023May 15, 2023Aug 14, 2023Nov 14, 2023Mar 21, 2024May 16, 2024Aug 14, 2024Nov 12, 2024Feb 21, 2025May 15, 2025Aug 12, 2025Nov 12, 2025Dec 31, 2025May 13, 2026Jun 30, 2026
EPS Estimate-------------------------------------------------------------
EPS Actual200.96165.7454.52183.1785.6737.0398.85120.47170.99-169.3053.6791.97-93.3695.66119.01-49.69-0.30-47.381.2174.744.1549.75-7.19-415.9025.9269.0958.12-110.7817.6035.8217.00-16.0018.6948.7516.65-52.1534.2736.1420.049.3728.207.60-38.48-223.29-89.71-181.89-331.47-137.23-175.53-157.07-648.44-50.67-1.03-1.92-246.55-25.0563.78124.439.006.68-149.23
Surprise-------------------------------------------------------------
Timing--------------------Pre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketAfter-hours-Pre-market-Pre-marketPre-marketPre-marketPre-marketPre-market---Pre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-market-Pre-market-

Key Statistics & Ratios

Market Cap503.70B
Enterprise Value487.95B
Trailing P/E0.00
Forward P/E17.73
PEG Ratio0.00
Price / Sales2.11
Price / Book1.80
Revenue (TTM)239.07B
Gross Profit (TTM)102.10B
EBITDA14.01B
Profit Margin-0.34%
Operating Margin-12.57%
Return on Equity-0.28%
Return on Assets0.48%
Shares Outstanding51.71M
Shares Float34.78M
Beta1.16
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20211×
100.00Dec 29, 2021
20201×
100.00Dec 29, 2020
20141×
48.08Dec 29, 2014
20131×
38.46Dec 27, 2013
20121×
53.34Dec 27, 2012
20111×
53.34Dec 28, 2011
20101×
49.79Dec 29, 2010
20091×
49.79Dec 29, 2009
20081×
41.49Dec 29, 2008
20071×
53.94Dec 27, 2007
20061×
37.34Dec 27, 2006
20051×
29.05Dec 28, 2005
20041×
20.75Dec 29, 2004
20031×
41.49Dec 29, 2003
20021×
41.49Dec 27, 2002
19971×
27.44Jan 3, 1997
19961×
27.44Jan 3, 1996

Stock Splits

  • Dec 29, 20141.04:1
  • Dec 27, 20131.04:1
  • Dec 27, 20121.04:1
  • Dec 28, 20111.04:1
  • Apr 18, 201110:1
  • Dec 29, 20101.03:1